Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeted Protein Degradation to Overcome Resistance in Cancer Therapies: PROTAC and N-Degron Pathway. | Biomedicines | 2022 | 36140200 | PubTator, text mining | PubMed |
| CRL4CRBN E3 Ligase Complex as a Therapeutic Target in Multiple Myeloma. | Cancers (Basel) | 2022 | 36139651 | PubTator, text mining | PubMed |
| Recent Advances of Degradation Technologies Based on PROTAC Mechanism. | Biomolecules | 2022 | 36139095 | PubTator, text mining | PubMed |
| Cereblon covalent modulation through structure-based design of histidine targeting chemical probes. | RSC Chem Biol | 2022 | 36128501 | PubTator, text mining | PubMed |
| Evaluation of the Prognostic Significance of Cereblon Protein Expression in Multiple Myeloma. | Clin Lab | 2022 | 36125148 | PubTator, text mining | PubMed |
| Management of relapsed/refractory Chronic Lymphocytic Leukemia. | Am J Hematol | 2022 | 36125037 | PubTator, text mining | PubMed |
| Mechanism of immunomodulatory drug resistance and novel therapeutic strategies in multiple myeloma. | Hematology | 2022 | 36121114 | PubTator, text mining | PubMed |
| PROTACs: The Future of Leukemia Therapeutics. | Front Cell Dev Biol | 2022 | 36120561 | PubTator, text mining | PubMed |
| Reversal of IKZF1-induced glucocorticoid resistance by dual targeting of AKT and ERK signaling pathways. | Front Oncol | 2022 | 36119546 | PubTator, text mining | PubMed |
| Discovery and Structural Characterization of Small Molecule Binders of the Human CTLH E3 Ligase Subunit GID4. | J Med Chem | 2022 | 36117290 | PubTator, text mining | PubMed |
| Novel Design Strategies to Enhance the Efficiency of Proteolysis Targeting Chimeras. | ACS Pharmacol Transl Sci | 2022 | 36110375 | PubTator, text mining | PubMed |
| Von Hippel-Lindau disease: insights into oxygen sensing, protein degradation, and cancer. | J Clin Invest | 2022 | 36106637 | PubTator, text mining | PubMed |
| Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds. | Front Oncol | 2022 | 36106110 | PubTator, text mining | PubMed |
| Current perspectives on interethnic variability in multiple myeloma: Single cell technology, population pharmacogenetics and molecular signal transduction. | Transl Oncol | 2022 | 36103755 | PubTator, text mining | PubMed |
| Potential Role of Polyphenolic Flavonoids as Senotherapeutic Agents in Degenerative Diseases and Geroprotection. | Pharmaceut Med | 2022 | 36100824 | PubTator, text mining | PubMed |
| Generation of knock-in degron tags for endogenous proteins in mice using the dTAG system. | STAR Protoc | 2022 | 36097386 | PubTator, text mining | PubMed |
| Pyrvinium doubles against WNT-driven cancer. | J Biol Chem | 2022 | 36096200 | PubTator, text mining | PubMed |
| Discovery of novel potential CRBN modulators through structure-based virtual screening and bioassay. | J Mol Graph Model | 2022 | 36088765 | PubTator, text mining | PubMed |
| Functional genomics uncovers the transcription factor BNC2 as required for myofibroblastic activation in fibrosis. | Nat Commun | 2022 | 36088459 | PubTator, text mining | PubMed |
| High-performance multiplex drug-gated CAR circuits. | Cancer Cell | 2022 | 36084652 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=53